Tectonic Therapeutic (TECX) Common Equity (2017 - 2026)
Tectonic Therapeutic (TECX) reported Common Equity of $223.85 million for Q2 2026, down 21.1% from $283.77 million a year earlier and down 2.9% from the prior quarter.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Tectonic Therapeutic posted Common Equity of $251.33 million, up 78.5% from FY2024.
- Common Equity has a five-year compound annual growth rate of -0.2% (FY2020 to FY2025).
- By year, Common Equity came in at $140.78 million in FY2024, -$84.64 million in FY2023, -$45.65 million in FY2022 and $169.48 million in FY2021 (-33.4%).
- The Q2 2026 figure ranks as the lowest quarterly Common Equity since Q4 2024.
- Year over year, Common Equity gained in three of the last five quarters, with growth averaging 36.5%.
- The high point for year-over-year Common Equity in five years was Q4 2025 (growth of 78.5%); the low point was Q3 2022 (a decline of 49.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $230.42 million (Q1 2026), $251.33 million (Q4 2025) and $267.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Tectonic Therapeutic | 452.22 Mn | 452.22 Mn | - | 223.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223.85 Mn |
| Mar 31, 2026 | 230.42 Mn |
| Dec 31, 2025 | 251.33 Mn |
| Sep 30, 2025 | 267.53 Mn |
| Jun 30, 2025 | 283.77 Mn |
| Mar 31, 2025 | 301.04 Mn |
| Dec 31, 2024 | 140.78 Mn |
| Sep 30, 2024 | 150.36 Mn |
| Jun 30, 2024 | 166.37 Mn |
| Mar 31, 2024 | -99.57 Mn |
| Dec 31, 2023 | -84.64 Mn |
| Sep 30, 2023 | -79.78 Mn |
| Jun 30, 2023 | -70.00 Mn |
| Mar 31, 2023 | -59.82 Mn |
| Dec 31, 2022 | -45.65 Mn |
| Sep 30, 2022 | 98.09 Mn |
| Jun 30, 2022 | 118.34 Mn |
| Mar 31, 2022 | 143.16 Mn |
| Dec 31, 2021 | 169.48 Mn |
| Sep 30, 2021 | 193.57 Mn |
API Access
Tectonic Therapeutic Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TECX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TECX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TECX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();